Lecture 7 Flashcards

1
Q

What are the 2 branches of adaptive immunity?

A

Humoral (B-cells) and Cell-mediated (T-cells - CD4, CD8)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Humoral immunity

A

Antibody production, Main defence against bacteria and bacterial toxins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cell-mediated Immunity

A

Formation of a population of lymphocytes that attack and destroy infected cells (CD8), Main defense against viruses, fungi, parasites, cancers, and some bacteria, rejection of transplanted organs,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Chain of events when a foreign antigen enters the body

A
  • Recognition of foreign antigen
  • Proliferation of individual lymphocytes that are programmed to respond to the antigen form a large group (clone) of cells
  • Destruction of pathogen /infected cells by the responding lymphocytes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

T lymphocyte Response

A

Unable to respond to a foreign antigen (TCR) until a macrophage or dendritic cell (APC) cell has phagocytosed the antigen, digested it, and displayed on its cell membrane the antigen fragments combined with its own MHC proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

B Lymphocyte Response to antigen

A
  • Have immunoglobulin molecules (BCR) on their cell membranes that function as antigen receptors, and they can bind entire antigen molecules to their receptors (do not require MHC presentation)
  • Processed into fragments
  • Fragments displayed on the cell’s membrane with MHC class ll proteins for presentation and recognition by CD4 T-cells to enhance antibody production
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Antibodies

A

Globulins produced by plasma cells and can only recreate to specific antigen that induce its formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Antibody function

A
  • Activation of complement
  • Neutralization
  • Agglutination
  • Opsonization
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Types of antibodies

A
  • Immunoglobulin G (IgG)
  • Immunoglobulin A (IgA)
  • Immunoglobulin M (IgM)
  • Immunoglobulin E (IgE)
  • Immunoglobulin D (IgD)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

IgG

A
  • Smaller antibody
  • Principal antibody molecule in response to majority of infectious agents
  • Monomer shape
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

IgM

A
  • Large antibody; a macroglobulin – early production before IgG is produced
  • Responsible for immune control in early response
  • Expressed on surface as monomer – secreted form (pentamer)
  • Very efficient combining with fungi
  • Pentamer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

IgE

A
  • Found in minute quantities in blood; binds to mast cells, basophils/eosinophils
  • Concentration is increased in allergic individuals
  • Important in controlling parasitic infections
  • Monomer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

IgA

A
  • Produced by antibody-forming cells located in the respiratory and gastrointestinal mucosa (GI/respiratory and urogenital tract)
  • Combines with harmful ingested or inhaled antigens, forming antigen–antibody complexes
  • Dimer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

IgD

A
  • Found on cell membrane of B lymphocytes (Functions mainly as BCR) - no plasma cell
  • Present in minute quantities in blood
  • Monomer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What type of immunoglobulins are on Naïve B cells on their cell surface

A

IgM and IgD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What do plasma cells do?

A
  • Proliferation/Increased Ab production
  • Class switching – specialized effector functions.
  • Affinity Maturation – competition/ mutation
  • Memory (travel to spleen/BM)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Why do B-cells need T-cells

A

Ab production is weak and short lived with no memory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Methods of adaptive immunity control

A
  • Cytokines (direct/control immune response)
    -Tolerance (central/peripheral)
    -Regulatory cells
    -Activation vs. Anergy/Apoptosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Loss of control of Adaptive Immunity

A

Hypersensitivity or Autoimmunity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Cytokine for cell-mediated immunity

A

IL-2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Cytokines for Humoral immunity

A

IL-4 and IL-5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

IL-2

A

• Interleukin 2 is produced by T cells, It is the major growth factor for T cells. Also promotes the growth of B cells
• IL-2 acts on T cells in paracrine/autocrine fashion.
• Activation of T cells results in expression of IL-2R and the production of IL-2. promotes cell division.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

IL-4

A

• Interleukin 4 is produced by macrophages and Th2 cells.
• stimulates the development of Th2 cells from naïve Th cells and it promotes the growth of differentiated Th2 cells resulting in the production of an antibody response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

IL-5

A

Interleukin 5 is produced by Th2 cells and it functions to promote the growth and differentiation of B cells and eosinophils. It also activates mature eosinophils.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

TGF-Beta

A

• Transforming growth factor beta is produced by T cells and many other cell types. It is primarily an inhibitory cytokine.
• It inhibits the proliferation of T cells and the activation of macrophages. It also acts on cells to block the effects of pro-inflammatory cytokines.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

INF-y

A

• Interferon gamma is an important cytokine produced by primarily by Th1 cells, although it can also be produced by Tc and NK cells to a lesser extent.
• It has numerous functions in both the innate and adaptive immune systems.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Th1 pathogens

A

-(cell based) geared towards viral/ bacterial attacks in blood/ tissues
-Polarize cells of adaptive and innate immunity to promote cellular immunity most effective against these invaders –PROINFLAMMATORY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Th2 pathogens

A

-(humoral-antibody) geared towards parasitic/mucosal infections.
-ANTIIFLAMMATORY
-Antibody based
-basis of hygiene
-Hypothesis, Allergy IgE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Cytokine Positive feedback

A

Th1/2 cytokines enhance and encourage Th1/2 functions and uncommitted cells (IL-2/IL-4)

30
Q

Cytokine Negative feedback

A

Th1 inhibits Th2 functions and vice versa (IFNgamma/IL-10)

31
Q

Central Tolerance

A

T and B cells must not react to self antigens and be restricted to self MHC molecules

32
Q

Where do Immature T-cells go?

A

They go from bone marrow to the thymus from the blood

33
Q

How to TCRs remain diverse

A

They proliferate and rearrange gene segments

34
Q

Positive selection - MHC

A

Cells that recognize MHC-peptide complexes receive rescue signals that prevent apoptosis

35
Q

Negative Selection - self cells

A

Cells that survive positive selection exit the thymic cortex to the medulla where they are tested for tolerance to self-antigens

36
Q

AIRE(autoimmune regulator) gene

A

Causes transcription of a wide selection of organ-specific genes that create proteins that are usually only expressed in peripheral tissues

37
Q

Fetal development

A

Full complement when born, activity of thymus decreases over time with large drop in thymic function after puberty

38
Q

B-cells central tolerance

A

Decreased stringency of central tolerances mechanism compared to T-cells. B-cells continue to develop throughout life

39
Q

Positive B-cell selection

A

Activate B-cell maturation

40
Q

Negative B-Cell selection

A

Reaction to self

41
Q

Peripheral Tolerance

A

Naïve T-cells stay in circulation, don’t stay in LN, or tissues so they only encounter a portion of the antigens in our body (compartmentalization)

42
Q

Cell Anergy

A

Apoptosis; shut off the immune response (indirectly and directly)

43
Q

Indirect cell anergy

A

Fewer antigens present to stimulate an immune response (DCs die after a few days, without continued support from macrophages and DC activated cells will doe off)

44
Q

Direct anergy

A

Apoptosis and by molecular inhibition of immune functions (activated T cells are inherently pro apoptotic) •Tim-3
•PD1/ PD1L
•CTLA-4
All deactivate the immune response

45
Q

CTLA4-B7 binding

A

Makes less B7 molecules available for interaction with CD28; CTLA:B7 binding represses activation and block CD28 signalling (repression will shut down immune response)

46
Q

What does the lack of co-receptor signals mean

A

Anergy/death or compartmentalization

47
Q

T reg cells

A

T cells that regulate activation of other T cells and necessary to maintain peripheral tolerance to self antigens; Produce cytokines that shut down the immune system

48
Q

Natural T ref (nTreg)

A

Turn down immune response to self antigens

49
Q

Inducible or adaptive Treg cells

A

Generated to self and foreign antigen after an inflammatory immune response

50
Q

Hypersensitivity reactions

A

Allergy (Environment) and Autoimmunity (Self)

51
Q

Types of hypersensitivity reactions

A
  • Type I: Allergy (immediate)
  • Type II: Cytotoxic
  • Type III: Immune complex
  • Type IV: Delayed hypersensitivity or cell-mediated hypersensitivity
52
Q

Allergy response

A

IgE loading on mast cells, basophils, and eosinophils (mild reaction; rash, itching, swelling)

53
Q

Allergy treatment

A

Environmental control, antihistamines, steroids, leukotriene inhibitors, allergen immunotherapy. Antihistamine drugs often relieve many allergic symptoms; histamine is one of the mediators released from IgE-coated cells

54
Q

Anaphylaxis

A

Hypersensitivity reaction that may be life-threatening (fall in blood pressure and severe respiratory distress); Systemic response: peanuts, Bee sting, penicillin allergy
Require epinephrine to treat

55
Q

Biphasic anaphylaxis reaction

A

Have a less severe initial reaction and 24hrs later have a much worse one

56
Q

Atopic person

A

Allergy prone individual

57
Q

Environmental susceptibility

A

Hygiene hypothesis (overly clean can make you more susceptible to illness)

58
Q

Type 2: Cytotoxic

A

Antibody dependent (IgM, IgG) that combine with tissue or cell antigen creating lysis of cell or other membrane damage (examples: Autoimmune hemolytic anemia, blood transfusion reactions, Rh hemolytic disease, autoimmune glomerulonephritis)

59
Q

Type 3: Immune complex

A

Ag-Ab immune complexes deposited in tissues activate complement pathway; Neutrophils attracted to site, causing tissue damage (examples: Rheumatoid arthritis, systemic lupus erythematosus (SLE), some types of glomerulonephritis)

60
Q

Type 4: Cell-mediated, delayed hypersensitivity

A

Typically after 24-48 hours T lymphocytes are sensitized and activated on second contact with same antigen which induces inflammation and activates macrophages through lymphokines (Example: contact dermatitis, Diabetes Mellitus (T1), Rheumatoid arthritis)

61
Q

Treatment for autoimmune disease

A

Various immune suppressing drugs/therapies (Corticosteroids, cytotoxic drugs, NSAIDS, immunotherapy with various biologics, antibody treatments (monoclonal – blocking or IVIG), symptomatic)

62
Q

When can autoimmunity occur?

A

-Individual express MHC molecules that efficiently present self peptides (Two particular types of MHCII increase chance of type1 diabetes by 20 fold)
-Production of T and/or B cells that have receptors that recognize self (Random mix match, even identical twins will not share TCR repertoires (chance))
-Breakdown of tolerance mechanisms designed to eliminate these cells

63
Q

Potential causes of Autoimmunity

A

•Defects in central tolerance deletion/ survival
•Defects in T Reg function/ numbers
•Defective apoptosis mechanisms (+ve/-ve)
•Inadequate inhibitory receptor functions (CTLA/ Fas) •Chronic activation of APC’s, excessive T cell activation

64
Q

Autoimmunity development

A
  1. Genetic susceptibility
  2. Failure of self tolerance/immune control
  3. Infection/ injury
  4. Activation of APC’s
  5. Recruitment of auto-reactive
    lymphocytes
  6. Activation of auto-reactive Lymphocytes
  7. Tissue injury from auto immune attacks
  8. Auto immune disease
65
Q

Insulin dependent diabetes mellitus

A

Immune system targets insulin producing Beta cells in the pancreas (Islets of Langerhans) which is mediated by CTL activity, Dysfunctional natural Treg cells.

66
Q

Myasthenia Gravis

A

Self reactive antibodies bind to acetylcholine receptors which results in muscle weakness and paralysis

67
Q

Multiple Sclerosis

A

CNS inflammatory disease that is initiated by reactive T cells/ Macrophages causing chronic inflammation destroys myelin sheath protein, causing defect in sensory inputs

68
Q

Rheumatoid Arthritis

A

Systemic autoimmune disease; Cartilage protein targeted causing chronic joint inflammation (IgM, IgG antibody complexes form in joints)

69
Q

Lupus Erythematosus

A

Systemic: rash (forehead/ cheeks), inflammation of lungs, kidneys, joints, paralysis, convulsions; Breakdown in both T an B cell tolerance (lack of activation cell death may play a role)

70
Q

Genetic mutations associated with Autoimmune disorders include dysregulation of

A

-Treg (FoxP3)
-Cell activation (IL-2, IL-12, CD2/58, Blk)
-Activation inhibitors (IL-10, CTLA4)
-Apoptosis (Bim, Fas)
-HLA alleles (MHC)

71
Q

Which gender usually has an autoimmune disease

A

Women (80%), when makes get it they’re more severe

72
Q

Autoimmune treatment

A

Symptomatic/ Immunosuppression Drugs:
-Corticosteroids/anti-inflammatory
-Chemical T cell/ B cell inhibitors/Cytokine blockers (IL-2)
-mAb to block immune receptors on T/B cells or cytokines (TNFa)
-Pain control/physical therapy
-IVIG – block Fc receptors on cells